Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 18, 2020

Primary Completion Date

September 17, 2020

Study Completion Date

September 17, 2020

Conditions
COVID-19Respiratory Failure
Interventions
DEVICE

Active PBMT/sMF

The PBMT/sMF will be irradiated in the lower thorax and neck areas, with the patients in supine position. PBMT/sMF application time will be 60 seconds per site. The dose used in the lower thorax will be 31.50 J per site, a total of 6 sites will be irradiated, totalizing a dose of 189J. In addition, the dose used in the neck area (bilaterally) will be 31.50J per site, a total of 1 site (bilaterally) will be irradiated, totalizing a dose of 31.50J (bilaterally). PBMT/sMF will be applied using the direct contact method with light pressure on the skin.

DEVICE

Placebo PBMT/sMF

The placebo PBMT/sMF will be irradiated in the lower thorax and neck areas, with the patients in supine position. PBMT/sMF application time will be 60 seconds per site. The dose used for applications during the treatment will be 0 Joules (J) per site. The sounds and signals emitted from the device as well as the information displayed on the screen will be identical, regardless of the type of treatment (active or placebo). PBMT/sMF will be applied using the direct contact method with light pressure on the skin.

Trial Locations (1)

95700-068

Hospital Tacchini, Bento Gonçalves

All Listed Sponsors
collaborator

Hospital Tacchini/RS

UNKNOWN

lead

University of Nove de Julho

OTHER

NCT04386694 - Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19 | Biotech Hunter | Biotech Hunter